| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/26/2023 | 14.7% | Piper Sandler | $34 → $32 | Maintains | Overweight |
| 09/14/2023 | 21.86% | DA Davidson | $36.5 → $34 | Upgrades | Neutral → Buy |
| 07/31/2023 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 07/27/2023 | 32.62% | Keefe, Bruyette & Woods | $40 → $37 | Maintains | Outperform |
| 05/01/2023 | 29.03% | Raymond James | $43 → $36 | Maintains | Outperform |
| 04/27/2023 | 39.78% | Piper Sandler | $44 → $39 | Maintains | Overweight |
| 04/27/2023 | 50.54% | Keefe, Bruyette & Woods | $46 → $42 | Maintains | Outperform |
| 04/06/2023 | 54.12% | Raymond James | $45 → $43 | Maintains | Outperform |
| 01/30/2023 | 61.29% | Raymond James | $49 → $45 | Maintains | Market Outperform |
| 01/26/2023 | 61.29% | Piper Sandler | $49 → $45 | Maintains | Overweight |
| 10/31/2022 | 75.63% | Raymond James | $41 → $49 | Maintains | Outperform |
| 10/06/2022 | 46.95% | Raymond James | $43 → $41 | Maintains | Outperform |
| 08/18/2022 | 68.46% | Piper Sandler | $49 → $47 | Upgrades | Neutral → Overweight |
| 08/01/2022 | 50.54% | DA Davidson | $43 → $42 | Downgrades | Buy → Neutral |
| 08/01/2022 | 54.12% | Raymond James | $40 → $43 | Maintains | Outperform |
| 06/23/2022 | 43.37% | Raymond James | $44 → $40 | Maintains | Outperform |
| 05/02/2022 | 57.71% | Raymond James | $49 → $44 | Maintains | Outperform |
| 02/28/2022 | 75.63% | Raymond James | → $49 | Initiates Coverage On | → Outperform |
| 10/12/2021 | 86.38% | Piper Sandler | $49 → $52 | Downgrades | Overweight → Neutral |
| 06/16/2021 | 82.8% | Piper Sandler | $46 → $51 | Upgrades | Neutral → Overweight |
| 07/24/2020 | -10.39% | Piper Sandler | $26 → $25 | Maintains | Neutral |
| 06/19/2020 | — | DA Davidson | Downgrades | Buy → Neutral | |
| 06/18/2020 | -6.81% | Piper Sandler | $32 → $26 | Downgrades | Overweight → Neutral |
| 02/28/2020 | — | DA Davidson | Initiates Coverage On | → Buy | |
| 04/25/2019 | — | Gabelli & Co. | Upgrades | Hold → Buy | |
| 03/25/2019 | — | Piper Sandler | Upgrades | Hold → Buy |
What is the target price for First Bancorp (FBNC)?
The latest price target for First Bancorp (NASDAQ: FBNC) was reported by Piper Sandler on October 26, 2023. The analyst firm set a price target for $32.00 expecting FBNC to rise to within 12 months (a possible 14.70% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for First Bancorp (FBNC)?
The latest analyst rating for First Bancorp (NASDAQ: FBNC) was provided by Piper Sandler, and First Bancorp maintained their overweight rating.
When is the next analyst rating going to be posted or updated for First Bancorp (FBNC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of First Bancorp, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for First Bancorp was filed on October 26, 2023 so you should expect the next rating to be made available sometime around October 26, 2024.
Is the Analyst Rating First Bancorp (FBNC) correct?
While ratings are subjective and will change, the latest First Bancorp (FBNC) rating was a maintained with a price target of $34.00 to $32.00. The current price First Bancorp (FBNC) is trading at is $27.90, which is out of the analyst's predicted range.
